Private Market View

Linnaeus Therapeutics

Drug Discovery · Haddonfield, NJ · Founded 2016 · Privately Held (backing)

Last price · $/share
Implied valuation
$83.1M
Total raised
$35.6M
Last round
Seed Round
Feb 2026
What is Linnaeus Therapeutics worth?
$83.1Mlast known valuation

Linnaeus Therapeutics last raised $5.0M in its Seed Round (Feb 2026).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 8 rounds
  • ·The complete investor list — 8 names
  • ·Watchlist + deal alerts for Linnaeus Therapeutics
Create free account
No card required

Funding history

8 rounds
DateRoundRaisedPost-money
Feb 2026Seed Round$5.0M
Aug 2025Debt$1.3M
Aug 2024Early Stage VC$5.8M
Jan 2023Seed Round$3.1M
Jan 2023Accelerator/Incubator
Aug 2021Seed Round$4.3M
+ 2 earlier rounds · a free account shows the full history

How Linnaeus Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Linnaeus Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Linnaeus Therapeutics worth?
Linnaeus Therapeutics's last known valuation is $83.1M.
How much has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $35.6M in total funding across 8 recorded rounds.
When did Linnaeus Therapeutics last raise?
Linnaeus Therapeutics last raised in Feb 2026 (Seed Round), raising $5.0M.